Your browser doesn't support javascript.
loading
Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis.
Louis, Edouard; Paridaens, Kristine; Al Awadhi, Sameer; Begun, Jakob; Cheon, Jae Hee; Dignass, Axel U; Magro, Fernando; Márquez, Juan Ricardo; Moschen, Alexander R; Narula, Neeraj; Rydzewska, Grazyna; Freddi, Matthew J; Travis, Simon Pl.
Afiliação
  • Louis E; Hepato-Gastroenterology and Digestive Oncology Department, University and Centre Hospitalier Univestitaire (CHU) Liège, Liège, Belgium.
  • Paridaens K; Ferring International Center SA, Saint-Prex, Switzerland kristine.paridaens@ferring.com.
  • Al Awadhi S; Gastroenterology Department, Rashid Hospital, Dubai, UAE.
  • Begun J; Department of Gastroenterology, Mater Hospital Brisbane, Brisbane, Queensland, Australia.
  • Cheon JH; Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea (the Republic of).
  • Dignass AU; Department of Medicine I, Agaplesion Markus Hospital, Goethe-University, Frankfurt am Main, Germany.
  • Magro F; Department of Biomedicine, Unit of Pharmacology and Therapeutics, University of Porto, Porto, Portugal.
  • Márquez JR; Department of Gastroenterology, São João University Hospital, Porto, Portugal.
  • Moschen AR; Colorectal Surgery Department, Instituto de Coloproctologia ICO Clinica Las Americas, Medellin, Colombia.
  • Narula N; University Clinic for Internal Medicine, Johannes Kepler University, Linz, Austria.
  • Rydzewska G; Division of Gastroenterology, Department of Medicine and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
  • Freddi MJ; Clinical Department of Internal Medicine and Gastroenterology with Inflammatory Bowel Disease Subdivision, The Central Clinical Hospital of the Ministry of the Interior Affairs and Administration, Warsaw, Poland.
  • Travis SP; Collegium Medicum, Jan Kochanowski University of Kielce, Kielce, Poland.
BMJ Open Gastroenterol ; 9(1)2022 02.
Article em En | MEDLINE | ID: mdl-35165124
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Colite Ulcerativa Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: BMJ Open Gastroenterol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Colite Ulcerativa Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: BMJ Open Gastroenterol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Bélgica